The Score: Novo Nordisk, Oracle, Netflix, and More Stocks That Defined the Week - WSJ

1. Novo Nordisk's amycretin trial shows 22% weight loss; shares up 8.5%. 2. US sues Walgreens for unlawful opioid prescriptions; shares down 9.2%. 3. Oracle's AI project could involve $100 billion; shares gain 7.2%. 4. Netflix raises prices after record gains; shares jump 9.7%. 5. Procter & Gamble may raise prices if tariffs hit; shares up 1.9%.